Clinical Benefits of Preservative-Free Treatment for Glaucoma with a Focus on Preservative-Free Latanoprost
This review highlights the benefits of preservative-free topical glaucoma therapies and includes a targeted review of preservative-free latanoprost 0.005%. Recent technologic advancements including multidose preservative-free delivery systems and sustained-release drug delivery approaches are also discussed.
Authors
- Deepinder K. Dhaliwal (ORCID: https://orcid.org/0000-0002-6969-2389)
- Zeba A. Syed (ORCID: https://orcid.org/0000-0001-9261-3565)
- Darrell E White
- Aakriti Garg Shukla (ORCID: https://orcid.org/0000-0002-0765-8337)
- Inder Paul Singh
Institutions
- University of Pittsburgh (US)
- Columbia University Irving Medical Center (US)
- Westlake University (CN)
- Eye Center (SA)
- Wills Eye Hospital (US)
Publication Details
- Journal
- Ophthalmology and Therapy
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1007/s40123-025-01241-9
- Citations
- 2
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.41
Funders
- Nordic Pharma Group